Vincerx Pharma, Inc. (VINC) Balance Sheet
VINC balance sheet, 2024
December 31, 2024 · U.S. dollars$8.0M assets = $5.3M liabilities + $2.7M equity
Both columns are drawn to the same scale: what VINC owns equals what it owes plus shareholders’ equity. Hover a block for its value.
VINC financial health
Descriptive bands, not a rating. Fiscal 2024.
VINC balance sheet trends, 2019–2024
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1,0002019 | $8.0M2024 | +503.5%/yr | |
| Total liabilities | $44,0002019 | $5.3M2024 | +160.5%/yr | |
| Shareholders’ equity | −$44,0002019 | $2.7M2024 | — | |
| Cash & short-term investments | $684,7082019 | $5.0M2024 | +48.8%/yr | |
| Total debt | $4.2M2021 | $2.5M2023 | −22.6%/yr | |
| Net cash (debt) | $107.3M2021 | $10.3M2023 | −$97.0M | |
| Working capital | $747,0412019 | $1.1M2024 | +$381,959 | |
| Book value per share | −$0.032019 | $0.522024 | — | |
| Current ratio | 17.982019 | 1.212024 | −16.76 | |
| Debt / equity | 0.042021 | 0.222023 | +0.18 | |
| Shares outstanding | 1.4M2019 | 5.2M2024 | +29.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
VINC assets
VINC liabilities and equity
VINC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
VINC balance sheet
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $5.0M | $12.8M | $52.5M | $111.5M | $61.8M | $684,708 |
| Cash & equivalents | $5.0M | $12.8M | $11.7M | $111.5M | $61.8M | $684,708 |
| Short-term investments | — | $0 | $40.8M | $0 | — | — |
| Receivables | $1.0M | $1.0M | $1.4M | $0 | $0 | $0 |
| Inventory | $0 | $0 | −$1.2M | $0 | $0 | $0 |
| Other current assets | $382,000 | $907,000 | $3.4M | $382,000 | $1.3M | $106,333 |
| Total current assets | $6.4M | $14.7M | $56.0M | $111.8M | $63.1M | $791,041 |
| Property, plant & equipment (net) | $0 | $2.3M | $3.2M | $4.2M | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1.6M | $1.2M | $81,000 | $1.7M | $82,000 | $0 |
| Total assets | $8.0M | $18.2M | $59.3M | $117.7M | $63.2M | $1,000 |
| Liabilities | ||||||
| Accounts payable | $2.0M | $2.5M | $4.1M | $2.0M | $491,000 | $35,000 |
| Short-term debt | — | $1.2M | $1.0M | $738,000 | — | — |
| Deferred revenue | — | −$657,000 | — | $4.7M | — | — |
| Total current liabilities | $5.3M | $5.6M | $9.2M | $13.9M | $37.8M | $44,000 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $2.5M | $3.4M | $4.2M | $0 | — |
| Other long-term liabilities | $0 | $1.4M | $2.5M | $3.4M | $491,000 | $3.3M |
| Total liabilities | $5.3M | $7.0M | $11.6M | $17.4M | $5.5M | $44,000 |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $8,000 | $2,000 | $2,000 | $2,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$189.2M | −$159.1M | −$119.0M | −$56.0M | −$16.7M | −$45,000 |
| Accumulated other comprehensive income | $119,000 | $8,000 | −$26,000 | −$21,000 | — | −$1,000 |
| Total shareholders' equity | $2.7M | $11.2M | $47.7M | $100.3M | $25.4M | −$44,000 |
| Key figures | ||||||
| Total debt | — | $2.5M | $3.4M | $4.2M | — | — |
| Net cash (debt) | — | $10.3M | $49.0M | $107.3M | — | — |
| Working capital | $1.1M | $9.1M | $46.8M | $97.9M | $25.3M | $747,041 |
| Tangible book value | $2.7M | $11.2M | $47.7M | $100.3M | $25.4M | −$44,000 |
| Book value per share | $0.52 | $1.91 | $8.22 | $21.18 | $17.82 | −$0.03 |
| Shares outstanding | 5.2M | 5.9M | 5.8M | 4.7M | 1.4M | 1.4M |
| Current ratio | 1.21 | 2.63 | 6.11 | 8.04 | 1.67 | 17.98 |
| Quick ratio | 1.14 | 2.47 | 5.88 | 8.01 | 1.63 | 15.56 |
| Debt / equity | — | 0.22 | 0.07 | 0.04 | — | — |
| Equity / assets | 34.0% | 61.6% | 80.4% | 85.3% | 40.2% | −4,400.0% |
| Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $4.4M | $5.0M | $10.1M | $16.4M | $5.1M | $12.8M | $20.8M | $27.4M | $39.8M | $52.5M | $66.0M | $80.9M |
| Cash & equivalents | $4.4M | $5.0M | $2.9M | $7.9M | $5.2M | $12.8M | $15.1M | $6.7M | $4.5M | $11.7M | $45.8M | $80.9M |
| Short-term investments | — | — | $7.1M | $8.4M | — | $0 | $5.7M | $20.7M | $35.3M | $40.8M | $20.2M | — |
| Receivables | $0 | $1.0M | $1.1M | $1.0M | $1.0M | $1.0M | $1.1M | $1.4M | $354,000 | $1.4M | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $1 | $0 | $392,000 | −$748,000 | $0 | −$1.2M | $0 | $0 |
| Other current assets | $249,000 | $382,000 | $599,000 | $864,000 | $1.5M | $907,000 | $571,000 | $3.8M | $3.9M | $3.4M | $1.3M | $1.5M |
| Total current assets | $4.7M | $6.4M | $11.7M | $18.3M | $7.7M | $14.7M | $22.8M | $31.8M | $44.0M | $56.0M | $67.3M | $82.4M |
| Property, plant & equipment (net) | $0 | $0 | $1.5M | $1.8M | $2.1M | $2.3M | $2.6M | $2.8M | $3.1M | $3.2M | $3.5M | $3.7M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $1.6M | $1.7M | $1.5M | $1.3M | $1.2M | $874,000 | $624,000 | $354,000 | $81,000 | $1.6M | $1.6M |
| Total assets | $4.7M | $8.0M | $14.9M | $21.5M | $11.1M | $18.2M | $26.3M | $35.3M | $47.4M | $59.3M | $72.4M | $87.7M |
| Liabilities | ||||||||||||
| Accounts payable | $2.3M | $2.0M | $2.0M | $1.5M | $2.3M | $2.5M | $3.1M | $3.5M | $6.2M | $3.1M | $4.4M | $5.1M |
| Short-term debt | — | — | $1.3M | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.0M | $999,000 | $968,000 |
| Deferred revenue | — | — | — | — | — | — | $4.5M | $4.3M | — | — | — | — |
| Total current liabilities | $2.6M | $5.3M | $5.4M | $5.3M | $10.6M | $5.6M | $8.8M | $9.2M | $10.7M | $9.2M | $9.9M | $10.5M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | $0 | $1.6M | $1.9M | $2.2M | $2.5M | $2.8M | $3.0M | $3.3M | $3.4M | $3.7M | $3.9M |
| Other long-term liabilities | $0 | $0 | $415,000 | $747,000 | $1.1M | $1.4M | $1.7M | $2.0M | $2.3M | $2.5M | $2.7M | $2.9M |
| Total liabilities | $2.6M | $5.3M | $5.8M | $6.1M | $11.7M | $7.0M | $10.5M | $11.1M | $13.0M | $11.6M | $12.7M | $13.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1,000 | $8,000 | $3,000 | $3,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 | $2,000 |
| Retained earnings (deficit) | −$194.2M | −$189.2M | −$181.2M | −$173.3M | −$171.5M | −$159.1M | −$156.5M | −$146.8M | −$135.7M | −$121.3M | −$107.7M | −$90.8M |
| Accumulated other comprehensive income | $170,000 | $119,000 | $104,000 | $24,000 | $60,000 | $8,000 | $52,000 | $69,000 | $35,000 | −$26,000 | −$63,000 | $4,000 |
| Total shareholders' equity | $2.1M | $2.7M | $9.1M | $15.4M | −$622,000 | $11.2M | $15.7M | $24.1M | $34.5M | $47.7M | $59.7M | $74.4M |
| Key figures | ||||||||||||
| Total debt | — | — | $1.6M | $1.9M | $2.2M | $2.5M | $2.8M | $3.0M | $3.3M | $3.4M | $3.7M | $3.9M |
| Net cash (debt) | — | — | $8.4M | $14.5M | $2.9M | $10.3M | $18.0M | $24.3M | $36.5M | $49.0M | $62.3M | $77.0M |
| Working capital | $2.1M | $1.1M | $6.3M | $13.0M | −$3.0M | $9.1M | $14.0M | $22.7M | $33.3M | $46.8M | $57.3M | $71.9M |
| Tangible book value | $2.1M | $2.7M | $9.1M | $15.4M | −$622,000 | $11.2M | $15.7M | $24.1M | $34.5M | $47.7M | $59.7M | $74.4M |
| Book value per share | $0.39 | $0.52 | $1.64 | $2.77 | −$0.11 | $1.90 | $2.67 | $4.11 | $5.90 | $8.18 | $10.27 | $12.84 |
| Shares outstanding | 5.2M | 5.2M | 5.6M | 5.6M | 5.9M | 5.9M | 5.9M | 5.9M | 5.8M | 5.8M | 5.8M | 5.8M |
| Current ratio | 1.79 | 1.21 | 2.17 | 3.43 | 0.72 | 2.63 | 2.58 | 3.47 | 4.11 | 6.11 | 6.76 | 7.88 |
| Quick ratio | 1.69 | 1.14 | 2.06 | 3.27 | 0.58 | 2.47 | 2.47 | 3.14 | 3.75 | 5.88 | 6.63 | 7.74 |
| Debt / equity | — | — | 0.18 | 0.13 | — | 0.22 | 0.18 | 0.13 | 0.10 | 0.07 | 0.06 | 0.05 |
| Equity / assets | 44.1% | 34.0% | 60.9% | 71.8% | −5.6% | 61.6% | 59.9% | 68.4% | 72.6% | 80.4% | 82.5% | 84.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2025); data from EODHD.
VINC financial position
At the end of fiscal 2024 (December 31, 2024), Vincerx Pharma had total assets of $8.0 million (down 56.1% from a year earlier), total liabilities of $5.3 million and shareholders' equity of $2.7 million. Its current ratio was 1.21. In the latest quarter (ended March 31, 2025) total assets were $4.7 million and equity $2.1 million.
Related: VINC income statement, VINC cash flow statement, VINC key metrics. See the VINC stock overview for the latest quote and news.
VINC balance sheet FAQ
What are Vincerx Pharma's total assets?
Vincerx Pharma reported total assets of $8.0 million at the end of fiscal 2024 (December 31, 2024), compared with $18.2 million a year earlier.
How much cash does Vincerx Pharma have?
Vincerx Pharma held $5.0 million in cash and short-term investments at the end of fiscal 2024.
What is Vincerx Pharma's book value?
Vincerx Pharma's shareholders' equity (book value) was $2.7 million at the end of fiscal 2024, or $0.52 per share.
What is Vincerx Pharma's current ratio?
Vincerx Pharma had current assets of $6.4 million and current liabilities of $5.3 million, a current ratio of 1.21 (it can cover its short-term obligations).